Large gap with delayed quotes
|
Last quote
02/28/2026
-
02:00:00
|
Bid
02/27/2026 -
21:59:59
|
Bid Volume |
Ask
02/27/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
451.76
+4.67
(
+1.04% )
|
451.57
|
40 |
452.07
|
160 |
Analysis date: 24.02.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 23.01.2026.
Interest
Very weak
Very weak
One star since 20.02.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 02.01.2026 at a price of 571.02.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 03.02.2026.
4wk Rel Perf
-24.43%
-24.43%
The four-week dividend-adjusted underperformance versus SP500 is 24.43%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 23.01.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by 0.00%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.92%.
Mkt Cap in $bn
12.55
12.55
With a market capitalization >$8bn, MEDPACE HOLDINGS is considered a large-cap stock.
G/PE Ratio
0.81
0.81
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
19.72
19.72
The estimated PE is for the year 2028.
LT Growth
15.98%
15.98%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
10
10
Over the last seven weeks, an average of 10 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
85
85
For 1% of index variation, the stock varies on average by 0.85%.
Correlation
0.24
0.24
Stock movements are strongly independent of index variations.
Value at Risk
106.17
106.17
The value at risk is estimated at USD 106.17. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.11.2020
27.11.2020